Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Cancer Science|November 21, 2008
l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasmsKyoichi Kaira, Noboru Oriuchi, Hisao Imai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 30, 2012
Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PETPattama Wiriyasermkul, Shushi Nagamori, Hideyuki Tominaga, et al.
Nuclear Medicine and Biology|November 9, 2010
Comparison of L-type amino acid transporter 1 expression and L-[3-18F]-α-methyl tyrosine uptake in outcome of non-small cell lung cancerKyoichi Kaira, Noboru Oriuchi, Kimihiro Shimizu, et al.
Annals of Nuclear Medicine|January 9, 2010
Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancyTomohiro Ishikita, Noboru Oriuchi, Tetsuya Higuchi, et al.
Annals of Surgical Oncology|July 9, 2010
18F-FAMT-PET is useful for the diagnosis of lymph node metastasis in operable esophageal squamous cell carcinomaMakoto Sohda, Hiroyuki Kato, Shigemasa Suzuki, et al.
Cancer Science|July 29, 2016
Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinomaYasuhiro Ohshima, Kyoichi Kaira, Aiko Yamaguchi, et al.
Annals of Nuclear Medicine|April 12, 2007
Diagnosis of maxillofacial tumor with L-3-[18f]-fluoro-alpha-methyltyrosine (FMT) PET: a comparative study with FDG-PETMitsuyuki Miyakubo, Noboru Oriuchi, Yoshito Tsushima, et al.
Anticancer Research|December 29, 2010
Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancerHisao Imai, Kyoichi Kaira, Noboru Oriuchi, et al.
Pageof 15